Ocular Therapeutix, Inc. (OCUL)
Ocular Therapeutix Market Cap: 2.586B for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 52.54B |
| Hologic, Inc. | 16.60B |
| Vertex Pharmaceuticals, Inc. | 115.03B |
| Bristol Myers Squibb Co. | 109.81B |
| Krystal Biotech, Inc. | 7.149B |
Market Cap Related Metrics
| PS Ratio | 37.75 |
| PEG Ratio | -0.9567 |
| Price to Book Value | 10.02 |
| Price | 12.14 |
| Earnings Yield | -11.83% |
| PEGY Ratio | -0.9567 |